Correction: Microglial 5-LOX-activating protein antagonism alleviates leukotriene-driven neuroinflammation - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Inhibition of Microglial 5-LOX-Activating Protein Mitigates Neuroinflammation Induced by Leukotrienes

  • By

  • Julia Konings

  • Fleur Mingneau

  • Serhii Chornyi

  • Cathrin E. Hansen

  • Rianne T. M. van der Burgt

  • Tessa G. van Elk

  • Laura Bolkaerts

  • Bo Batens

  • Gábor Tóth

  • Ingela Lanekoff

  • Frédéric M. Vaz

  • Alessio Cardilli

  • Marie Sels

  • Susanne M. A. van der Pol

  • Helga E. de Vries

  • Martin Giera

  • Oliver Werz

  • Sofie Kessels

  • Sanne G. S. Verberk

  • Jeroen F. J. Bogie

  • Merel Rijnsburger

  • Jerome J. A. Hendriks

  • Gijs Kooij

  • September 4, 2026

Share

Clinical Scorecard: Correction: Inhibition of Microglial 5-LOX-Activating Protein Mitigates Neuroinflammation Induced by Leukotrienes

At a Glance

CategoryDetail
ConditionNeuroinflammation
Key MechanismsInhibition of microglial 5-LOX-Activating Protein
Target PopulationIndividuals with neuroinflammation
Care SettingNeuropathology

Key Highlights

  • Correction of author's name from 'Rianne T. M. van der Brugt' to 'Rianne T. M. van der Burgt'
  • Published in Acta Neuropathologica
  • DOI 10.1007/s00401-026-03055-w
  • Volume 152, article 16
  • Correction pertains to the original article

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Not specified

          Not specified

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Related Content